Clinical Trials Logo

Clinical Trial Summary

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with DD-CKD


Clinical Trial Description

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the maintenance treatment of anemia in subjects with DD-CKD ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02892149
Study type Interventional
Source Akebia Therapeutics
Contact Akebia Therapeutics
Phone 617-844-6128
Email trials@akebia.com
Status Recruiting
Phase Phase 3
Start date August 2016
Completion date September 2019